Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Endometrial Neoplasms × Imatinib Mesylate × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Philadelphia Chromosome 2 Bronchiolitis Obliterans Syndrome 2 Translocation, Genetic 1 Recurrence 1 Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) 1 Pathologic Processes 1 Neoplasms by Histologic Type 1 Leukemia, Myeloid 1 Leukemia 1 Hematologic Diseases 1 Graft vs Host Disease 1 Bone Marrow Diseases 1

Interventions

pembrolizumab 3 Paclitaxel 3 Carboplatin 2 ulixertinib 1 trastuzumab biosimilar HLX02 1 trametinib 1 sapanisertib 1 sacituzumab govitecan 1 relatlimab 1 pertuzumab 1 palbociclib 1 osimertinib 1 omipalisib 1 olaparib 1 lenvatinib 1 larotrectinib 1 ipatasertib 1 erdafitinib 1 durvalumab 1 defactinib 1 dabrafenib 1 copanlisib 1 capivasertib 1 binimetinib 1 adavosertib 1 X-Rays 1 Trastuzumab 1 Taxes 1 Sunitinib 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡